(Q34512108)

2 August 2017

1 reference

title

Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Janardan K Reddy

1

1 reference

PubMed ID

16603729

2 August 2017

M Sambasiva Rao

series ordinal

2

1 reference

2 August 2017

1 May 2006

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

2 August 2017

1 reference

2 August 2017

290

1 reference

2 August 2017

G852-8

1 reference

2 August 2017

5

1 reference

Nonalcoholic fatty liver disease

2 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

Non-alcoholic fatty liver disease: an emerging pathological spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00521.2005

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00521.2005

1 reference

2 August 2017

1 reference

PubMed ID

16603729